TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Skandinavisk BioTech AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
515
|
505
|
570 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
134
|
69
|
90 |
| EBITDA |
124
|
61
|
89 |
| Total assets |
498
|
812
|
821 |
| Current assets |
358
|
604
|
614 |
| Current liabilities |
300
|
85
|
85 |
| Equity capital |
198
|
670
|
683 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
39.8%
|
82.5%
|
83.2% |
| Turnover per employee |
515
|
505
|
570 |
| Profit as a percentage of turnover |
26.0%
|
13.7%
|
15.8% |
| Return on assets (ROA) |
27.1%
|
8.5%
|
11.0% |
| Current ratio |
119.3%
|
710.6%
|
722.4% |
| Return on equity (ROE) |
67.7%
|
10.3%
|
13.2% |
| Change turnover |
-13
|
-9
|
194 |
| Change turnover % |
-2%
|
-2%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.